A148 EBV STATUS AND IMMUNOSUPPRESSANT USE IN IBD PATIENTS WHO SUBSEQUENTLY DEVELOP LYMPHOMA: A RETROSPECTIVE AND PROSPECTIVE STUDY

BACKGROUND: Immunosuppressive agents have revolutionized the treatment of inflammatory bowel disease (IBD). However, a number of studies over the last decade have identified a concerning link between immunosuppression and lymphoproliferative disorders (LPDs). These LPDs have been associated with Eps...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Can Assoc Gastroenterol
Main Authors: Reeson, M, Ambrosio, L, Lam, G Y, Fedorak, R, Dieleman, L A, Kroeker, K I, Huang, V, Peters, A, Halloran, B P
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Paper Sessions
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.148
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki